Company profile
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Anacor Pharmaceuticals Inc
SEC CIK
Corporate docs
IRS number
251854385
Latest filings (excl ownership)
15-12B
Securities registration termination
5 Jul 16
EFFECT
Notice of effectiveness
29 Jun 16
EFFECT
Notice of effectiveness
29 Jun 16
EFFECT
Notice of effectiveness
29 Jun 16
EFFECT
Notice of effectiveness
29 Jun 16
25-NSE
Exchange delisting
24 Jun 16
8-K
Pfizer Completes Acquisition of Anacor
24 Jun 16
POS AM
Prospectus update (post-effective amendment)
24 Jun 16
POS AM
Prospectus update (post-effective amendment)
24 Jun 16
POS AM
Prospectus update (post-effective amendment)
24 Jun 16
Latest ownership filings
SC 13G/A
Anacor Pharmaceuticals, Inc.
11 Jul 16
SC 13G/A
Anacor Pharmaceuticals, Inc.
11 Jul 16
4
Keith R Leonard
24 Jun 16
4
Lee Zane
24 Jun 16
4
Lucy Shapiro
24 Jun 16
4
WENDALL WIERENGA
24 Jun 16
4
Ryan T Sullivan
24 Jun 16
4
VINCENT P IPPOLITO
24 Jun 16
4
Anders D Hove
24 Jun 16
4
PAUL L BERNS
24 Jun 16
Institutional ownership, Q4 2021
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 17.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Byrne Asset Management | 17.00 | $0.00 |